Related Experiment Video
Updated: Aug 30, 2026

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model
Published on: November 29, 2024
Cardiovascular disease in patients who have diabetes
1Division of Endocrinology, Diabetes, and Metabolism, Diabetes Research Institute, University of Miami School of Medicine, 1450 NW 10th Avenue (R77), Miami, FL 33136, USA. rgoldber@med.miami.edu
Insights
Aggressively managing cardiovascular risk factors like dyslipidemia and hypertension is key for diabetes patients. Combining these interventions with appropriate antihyperglycemic therapies significantly reduces cardiovascular events and mortality.
Area of Science:
- Cardiology
- Endocrinology
- Metabolic Diseases
Background:
- Cardiovascular disease is the leading cause of death in diabetic patients.
- Diabetes management requires addressing multiple clustered cardiovascular risk factors.
Purpose of the Study:
- To highlight the benefits of aggressive, multifactorial risk factor intervention in diabetes management.
- To emphasize the role of antihyperglycemic therapies in cardiovascular risk reduction.
Main Methods:
- Review of clinical trials focusing on aggressive goal setting for dyslipidemia, hypertension, and procoagulant states.
- Analysis of the impact of antihyperglycemic therapies on cardiovascular outcomes.
Main Results:
- Multifactorial risk factor intervention significantly reduces cardiovascular events and mortality in patients with diabetes.
- Effective control of hyperglycemia alone has a modest impact, but antihyperglycemic choices enhance benefits.
Conclusions:
- Comprehensive management of cardiovascular risk factors is crucial for improving outcomes in diabetes.
- Emerging antihyperglycemic agents and early interventions show promise for preventing cardiovascular complications.
Abstract:
Although cardiovascular disease continues to be the major cause of morbidity and mortality in diabetes, the understanding that multiple risk factor intervention is the cornerstone of diabetes management is leading to significant benefits for patients. Aggressive goal setting for modifiable cardiovascular risk factors that cluster in patients with diabetes, such as dyslipidemia, hypertension, and a procoagulant state, and judicious selection of efficacious therapies have been shown to produce significant reductions in cardiovascular events, and in some cases mortality, in controlled clinical trials. Although effective control of hyperglycemia per se has at most modest impact, the choice and application of antihyperglycemic therapies add to the benefit. In addition, newer agents and early intervention in prediabetic and diabetic individuals hold promise for even greater success in the prevention of this important complication of diabetes.
Related Concept Videos
Complications of Diabetes Mellitus
Cardiovascular Drugs: Classification based on Therapeutic Indications
Diabetic Retinopathy
Coronary Artery Disease I: Introduction
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Diabetes: Symptoms, Diagnosis, and Complications